Oncofit Solutions Unveils Ascotfit - HD: Revolutionizing Clinical Use of High-Dose Vitamin C

Oncofit Solutions launches Ascotfit – HD, a high-dose Vitamin C injection formulated for various therapeutic applications. This innovation aims to support integrative oncology, anti-aging, and wellness, enhancing treatment protocols such as oxidative stress reduction and immune function support. The product is set for international distribution following stringent quality checks.

Oncofit Solutions, a leader in integrative health and specialty pharmaceuticals, announces the launch of Ascotfit – HD, a high-dose Vitamin C injection.

The innovative product promises to enhance protocols in integrative oncology, anti-aging, and wellness by delivering 25 grams of pharmaceutical-grade Vitamin C per 50 ml vial.

Ensuring international standards, Ascotfit – HD is manufactured in a GMP-certified facility, marking its suitability for global markets. Oncofit emphasizes that this breakthrough meets the demand for high-dose Vitamin C in various therapies.

(With inputs from agencies.)